Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,438,555,915
+$32,296,266 QoQ
Shares Held
5,664,275
-1.5% QoQ
Ownership
0.235%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#44
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 0%
None 3%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $65,843,394,868 across 16 Drug Manufacturers - General names. JNJ ranks #2 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
51,322,720 | $61,558,015,176 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
5,664,275 | $1,438,555,915 | |
| 3 | ABBV |
AbbVie Inc.
|
4,007,446 | $1,008,433,708 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,286,803 | $936,354,184 | |
| 5 | AMGN |
Amgen Inc
|
1,067,124 | $386,426,938 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,236,299 | $186,475,541 | |
| 7 | PFE |
Pfizer Inc
|
6,711,470 | $161,612,193 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
476,166 | $60,158,808 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,438,555,915 | 5,664,275 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,406,259,649 | 5,752,985 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $1,238,635,065 | 5,985,190 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $1,137,586,369 | 6,135,187 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $915,983,549 | 5,996,619 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,003,661,187 | 6,051,985 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $879,999,533 | 6,084,909 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,006,988,816 | 6,213,679 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $921,902,150 | 6,307,486 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,022,752,129 | 6,465,340 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,048,535,423 | 6,689,648 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $1,063,184,542 | 6,826,225 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,152,406,018 | 6,962,337 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,099,342,460 | 7,092,532 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,260,481,834 | 7,135,476 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,169,168,003 | 7,157,003 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,293,473,652 | 7,286,765 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,286,705,215 | 7,260,087 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,245,958,060 | 7,283,323 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,170,900,837 | 7,250,160 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $1,205,433,381 | 7,317,187 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $1,274,165,115 | 7,752,754 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $1,241,584,507 | 7,889,087 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,197,261,690 | 8,041,790 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $1,115,589,518 | 7,932,799 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $998,618,673 | 7,615,486 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||